| Physicians treating patients with early-stage lung cancer face a conundrum: choosing potentially helpful yet toxic therapies such as chemotherapy, radiation or immunotherapy to knock out the cancer and lessen the risk of it spreading to the brain, or waiting to see if lung surgery alone proves sufficient. | |
|
| The therapeutic potential of and molecular mechanisms through which dietary interventions impact a wide range of human diseases. | |
|
| A high impact study led by Daniel Spratt, M.D., Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer. | |
|
| SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, and the French Kidney Cancer Research Network collaborated on a study using a multimodal algorithm to help predict post-operative outcomes for those facing renal cell carcinoma, with the results recently published in npj Precision Oncology. | |
|
| A multidisciplinary research team at Gladstone Institutes, led by Senior Investigator Katie Pollard, PhD, has received $5 million in funding through a newly launched grant program designed to ignite a fresh wave of cancer discoveries using computational biology and artificial intelligence. | |
|
| Breakthrough in Brain Cancer Treatment: Dual-Target CAR T Cell Therapy Shows Promise in Early Clinical Trial. | |
|
| Surviving childhood cancer does not always mean a clean bill of health, as the treatments that eradicate those cancers can put adult survivors at risk of new cancers and other serious health problems. | |